Omalizumab: A useful tool for inducing tolerance to bee venom immunotherapy.
作者信息
Ricciardi L
机构信息
Allergy and Clinical Immunology Unit- University of Messina, Italy.
出版信息
Int J Immunopathol Pharmacol. 2016 Dec;29(4):726-728. doi: 10.1177/0394632016670920. Epub 2016 Sep 27.
Abstract
摘要
相似文献
1
Omalizumab: A useful tool for inducing tolerance to bee venom immunotherapy.
Int J Immunopathol Pharmacol. 2016 Dec;29(4):726-728. doi: 10.1177/0394632016670920. Epub 2016 Sep 27.
2
Immunotherapy and biologicals for the treatment of allergy to Hymenoptera stings.
Expert Opin Biol Ther. 2019 Sep;19(9):919-925. doi: 10.1080/14712598.2019.1632286. Epub 2019 Jun 21.
3
Changes in the levels of anti-phospholipase A2 and hyaluronidase antibodies during bee venom immunotherapy.
Monogr Allergy. 1983;18:150-2.
4
Rush venom immunotherapy program for honeybee sting sensitivity.
J Allergy Clin Immunol. 1979 May;63(5):340-7. doi: 10.1016/0091-6749(79)90129-5.
5
Venom immunotherapy.
N Engl J Med. 2004 Nov 11;351(20):2129-30; author reply 2129-30. doi: 10.1056/NEJM200411113512021.
6
IgE-Api m 4 Is Useful for Identifying a Particular Phenotype of Bee Venom Allergy.
J Investig Allergol Clin Immunol. 2016;26(6):355-361. doi: 10.18176/jiaci.0053.
7
Total and Honeybee Venom-Specific Serum IgG4 and IgE in Beekeepers.
J Investig Allergol Clin Immunol. 2017;27(2):146-148. doi: 10.18176/jiaci.0141.
8
A control theoretic approach to venom immunotherapy with state jumps.
Annu Int Conf IEEE Eng Med Biol Soc. 2010;2010:742-5. doi: 10.1109/IEMBS.2010.5626304.
9
Sub-class of IgG anti-bee venom antibody produced during bee venom immunotherapy and its relationship to long-term protection from bee stings and following termination of venom immunotherapy.
Clin Allergy. 1986 Jul;16(4):317-22. doi: 10.1111/j.1365-2222.1986.tb01963.x.
10
[Skin tests, total IgE and venom specific IgE and IgG4 in serum of bee-keepers].
Pneumonol Alergol Pol. 1993;61(7-8):342-5.
引用本文的文献
1
Free-IgE as a Predictor of Responsiveness to Omalizumab in Oral Corticosteroid-Dependent Asthma Patients.
Int J Mol Sci. 2025 Mar 21;26(7):2852. doi: 10.3390/ijms26072852.
2
The Incredible Adventure of Omalizumab.
Int J Mol Sci. 2024 Mar 6;25(5):3056. doi: 10.3390/ijms25053056.
3
Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in Mastocytosis.
Diagnostics (Basel). 2024 Jan 5;14(2):123. doi: 10.3390/diagnostics14020123.
4
Clinical and experimental treatment of allergic asthma with an emphasis on allergen immunotherapy and its mechanisms.
Clin Exp Immunol. 2023 Apr 7;212(1):14-28. doi: 10.1093/cei/uxad031.
5
Pathophysiological, Cellular, and Molecular Events of the Vascular System in Anaphylaxis.
Front Immunol. 2022 Mar 8;13:836222. doi: 10.3389/fimmu.2022.836222. eCollection 2022.
6
Omalizumab for prevention of anaphylactic episodes in a patient with severe mosquito allergy.
Clin Case Rep. 2021 Oct 21;9(10):e04935. doi: 10.1002/ccr3.4935. eCollection 2021 Oct.
7
Omalizumab ensures compatibility to bee venom immunotherapy (VIT) after VIT-induced anaphylaxis in a patient with systemic mastocytosis.
Allergol Select. 2021 Mar 11;5:128-132. doi: 10.5414/ALX02196E. eCollection 2021.
8
Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes.
Front Immunol. 2020 Oct 22;11:579409. doi: 10.3389/fimmu.2020.579409. eCollection 2020.
9
Bee Venom Immunotherapy: Current Status and Future Directions.
Clin Rev Allergy Immunol. 2020 Jun;58(3):326-341. doi: 10.1007/s12016-019-08752-x.
10
Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers.
J Asthma Allergy. 2018 Jun 20;11:121-142. doi: 10.2147/JAA.S159411. eCollection 2018.
本文引用的文献
1
Anaphylaxis to insect stings.
Immunol Allergy Clin North Am. 2015 May;35(2):287-302. doi: 10.1016/j.iac.2015.01.007. Epub 2015 Mar 6.
2
Pre-treatment by omalizumab allows allergen immunotherapy in children and young adults with severe allergic asthma.
Pediatr Allergy Immunol. 2014 Dec;25(8):829-32. doi: 10.1111/pai.12306. Epub 2014 Dec 18.
3
The bee sting that was not: an unusual case of hymenoptera anaphylaxis averted in a patient treated with omalizumab for asthma.
Case Rep Med. 2014;2014:138963. doi: 10.1155/2014/138963. Epub 2014 Aug 12.
4
Treatment with a combination of omalizumab and specific immunotherapy for severe anaphylaxis after a wasp sting.
Int J Immunopathol Pharmacol. 2014 Jan-Mar;27(1):109-12. doi: 10.1177/039463201402700114.
5
Omalizumab mitigates anaphylaxis during ultrarush honey bee venom immunotherapy in monoclonal mast cell activation syndrome.
J Allergy Clin Immunol Pract. 2013 Nov-Dec;1(6):687-8. doi: 10.1016/j.jaip.2013.07.004. Epub 2013 Sep 8.
6
Omalizumab and hypersensitivity reactions.
Curr Opin Allergy Clin Immunol. 2013 Feb;13(1):19-24. doi: 10.1097/ACI.0b013e32835bf3f5.
7
Venom immunotherapy for preventing allergic reactions to insect stings.
Cochrane Database Syst Rev. 2012 Oct 17;10(10):CD008838. doi: 10.1002/14651858.CD008838.pub2.
8
Safety of hymenoptera venom immunotherapy: a systematic review.
Expert Opin Pharmacother. 2011 Nov;12(16):2527-32. doi: 10.1517/14656566.2011.616494. Epub 2011 Sep 2.
9
Omalizumab monotherapy for bee sting and unprovoked "anaphylaxis" in a patient with systemic mastocytosis and undetectable specific IgE.
Ann Allergy Asthma Immunol. 2010 Jun;104(6):537-9. doi: 10.1016/j.anai.2010.04.011.
10
Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma.
J Allergy Clin Immunol. 2010 Feb;125(2):383-9. doi: 10.1016/j.jaci.2009.11.022.
Zotero 插件